Milic, Gordana (55710825100)Gordana (55710825100)MilicRistic, Masa (59245633600)Masa (59245633600)RisticMilosevic, Milica (59244818100)Milica (59244818100)MilosevicMitovic, Nikola (57230889700)Nikola (57230889700)MitovicDimitrijevic, Ljubica (59246267500)Ljubica (59246267500)DimitrijevicJesic Petrovic, Tanja (58700977300)Tanja (58700977300)Jesic PetrovicSalovic, Bojana (58700977400)Bojana (58700977400)Salovic2025-06-122025-06-122024https://doi.org/10.1177/11795514241267185https://www.scopus.com/inward/record.uri?eid=2-s2.0-85200354078&doi=10.1177%2f11795514241267185&partnerID=40&md5=093ab5baa79090c531819883e90f4684https://remedy.med.bg.ac.rs/handle/123456789/1386COVID-19, a global epidemic of infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), not only initially refers to acute manifestations but also chronic symptoms known as Long COVID-19. Long COVID-19 represents a significant burden to healthcare systems worldwide. This syndrome encompasses a wide range of continuing health problems with variable durations and consequences for patients’ everyday lives. A notable aspect of Long COVID-19 is the emergence of new-onset autoimmune diseases that could be triggered in predisposed patients with altered immune responses. Common autoimmune conditions that arise in post-COVID patients include autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, Guillain-Barre syndrome, etc., but with unclear evidence of associated disease occurrence. We present a case of a female rheumatoid arthritis patient who developed autoimmune thyroid disease, latent autoimmune diabetes of adults (LADA), and pernicious anemia after SARS-CoV-2 infection. © The Author(s) 2024.autoimmune diseaseschronic autoimmune thyroiditislatent autoimmune diabetes in adults (LADA)pernicious anemiaPost-COVID-19 syndrome